StonvexLoading…
StonvexStonvexStonvexCore line items from LDOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $4.38B | $17.11B | $12.91B | $8.46B |
Operating Income | $508.00M | $2.11B | $1.64B | $1.10B |
Net Income | $328.00M | $1.45B | $1.12B | $754.00M |
EPS (Diluted) | $2.56 | $11.14 | $8.62 | $5.80 |
Total Assets | $15.39B | $13.49B | $13.54B | $13.55B |
Total Liabilities | $10.32B | $8.53B | $8.59B | $8.84B |
Cash & Equivalents | $457.00M | $1.11B | $974.00M | $930.00M |
Free Cash Flow OCF − CapEx | $270.00M | $1.63B | $1.17B | $493.00M |
Shares Outstanding | 125.78M | 126.38M | 127.85M | 128.30M |